Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad, Institut Pasteur Extend Alliance Through End of Decade

NEW YORK, Jan. 4 (GenomeWeb News) - Bio-Rad Laboratories and the Institut Pasteur have extended their cooperation an additional four years, Bio-Rad said today.

 

The agreement, signed in Paris last month, gives Bio-Rad exclusive commercialization rights to Pasteur's research developments in the areas of virology, microbiology, physiology, biochemistry, parasitology and mycology, Bio-Rad said.

 

Norman Schwartz, president of the Hercules, Calif.-based company, said that Institut Pasteur "provides important innovations affecting blood virus testing," and that the institute's research is "closely aligned" with Bio-Rad's goal to supply the healthcare community with diagnostic tools.  

 

Bio-Rad and Pasteur have been collaborating since 1990, the company said.

 

Financial details of the agreement were not dislosed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.